BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16842969)

  • 1. Ligand-specific receptor states: implications for opiate receptor signalling and regulation.
    Piñeyro G; Archer-Lahlou E
    Cell Signal; 2007 Jan; 19(1):8-19. PubMed ID: 16842969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional selectivity of opioid receptors ligands].
    Audet N; Archer-Lahlou E; Richard-Lalonde M; Piñeyro-Filpo G
    Med Sci (Paris); 2010; 26(8-9):734-9. PubMed ID: 20819711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse agonists: tools to reveal ligand-specific conformations of G protein-coupled receptors.
    Prather PL
    Sci STKE; 2004 Jan; 2004(215):pe1. PubMed ID: 14722344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane signalling complexes: implications for development of functionally selective ligands modulating heptahelical receptor signalling.
    Piñeyro G
    Cell Signal; 2009 Feb; 21(2):179-85. PubMed ID: 18790047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of G protein-coupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins.
    Hendriks-Balk MC; Peters SL; Michel MC; Alewijnse AE
    Eur J Pharmacol; 2008 May; 585(2-3):278-91. PubMed ID: 18410914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11.
    Karakoula A; Tovey SC; Brighton PJ; Willars GB
    Eur J Pharmacol; 2008 Jun; 587(1-3):16-24. PubMed ID: 18457830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.
    Snook LA; Milligan G; Kieffer BL; Massotte D
    J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of G protein-coupled receptors.
    Deupi X; Kobilka B
    Adv Protein Chem; 2007; 74():137-66. PubMed ID: 17854657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of receptor-specific antibodies to study G-protein-coupled receptors.
    Gupta A; Devi LA
    Mt Sinai J Med; 2006 Jul; 73(4):673-81. PubMed ID: 16878273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.
    Beyermann M; Heinrich N; Fechner K; Furkert J; Zhang W; Kraetke O; Bienert M; Berger H
    Br J Pharmacol; 2007 Jul; 151(6):851-9. PubMed ID: 17533422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimerization of G protein-coupled receptors: new avenues for somatostatin receptor signalling, control and functioning.
    Durán-Prado M; Malagón MM; Gracia-Navarro F; Castaño JP
    Mol Cell Endocrinol; 2008 May; 286(1-2):63-8. PubMed ID: 18242821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid receptors.
    Waldhoer M; Bartlett SE; Whistler JL
    Annu Rev Biochem; 2004; 73():953-90. PubMed ID: 15189164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel aspects of G-protein-coupled receptor signalling--different ways to achieve specificity.
    Schulte G; Levy FO
    Acta Physiol (Oxf); 2007 May; 190(1):33-8. PubMed ID: 17428230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conformation-equilibrium model captures ligand-ligand interactions and ligand-biased signalling by G-protein coupled receptors.
    Roth S; Bruggeman FJ
    FEBS J; 2014 Oct; 281(20):4659-71. PubMed ID: 25145284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities.
    Seifert R; Dove S
    Mol Pharmacol; 2009 Jan; 75(1):13-8. PubMed ID: 19001067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulator of G-protein signaling (RGS) proteins in cancer biology.
    Hurst JH; Hooks SB
    Biochem Pharmacol; 2009 Nov; 78(10):1289-97. PubMed ID: 19559677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational complexity of G-protein-coupled receptors.
    Kobilka BK; Deupi X
    Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
    Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid systems in the dentate gyrus.
    Drake CT; Chavkin C; Milner TA
    Prog Brain Res; 2007; 163():245-63. PubMed ID: 17765723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.